<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Meet Mike, Your Generic Biologics Lobbyist</title>
	<atom:link href="http://www.pharmalot.com/2008/02/meet-mike-your-generic-biologics-lobbyist/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/02/meet-mike-your-generic-biologics-lobbyist/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 12 Mar 2010 23:08:13 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Ed Silverman</title>
		<link>http://www.pharmalot.com/2008/02/meet-mike-your-generic-biologics-lobbyist/#comment-150969</link>
		<dc:creator>Ed Silverman</dc:creator>
		<pubDate>Mon, 11 Feb 2008 17:01:51 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/meet-mike-your-generic-biologics-lobbyist/#comment-150969</guid>
		<description>Hi Larry,

I've received a copy of Coleman's resume and it lists employment at two other companies prior to his employment at Insmed. Between 2002 and 2006, it says he worked for a company called SomaLogic, and then briefly worked for SomaLogic before going to Insmed. I also spoke to Dr. Tad Koch, who runs a lab at the University of Colorado at Boulder, where Coleman was a postdoc and he helped fill in some of the info.

The math, however, is a little off - his work experience is more like seven years, but that's not counting time in Koch's lab, which to some is still advanced study, but to others may be considered akin to professionally paid work. I won't make a judgement on that distinction, but his work record does appear to extend beyond 11 months.

I hope this helps and thanks for writing in with that observation. Let's see if Coleman updates his Linkedin profile.

Regards
ed</description>
		<content:encoded><![CDATA[<p>Hi Larry,</p>
<p>I&#8217;ve received a copy of Coleman&#8217;s resume and it lists employment at two other companies prior to his employment at Insmed. Between 2002 and 2006, it says he worked for a company called SomaLogic, and then briefly worked for SomaLogic before going to Insmed. I also spoke to Dr. Tad Koch, who runs a lab at the University of Colorado at Boulder, where Coleman was a postdoc and he helped fill in some of the info.</p>
<p>The math, however, is a little off - his work experience is more like seven years, but that&#8217;s not counting time in Koch&#8217;s lab, which to some is still advanced study, but to others may be considered akin to professionally paid work. I won&#8217;t make a judgement on that distinction, but his work record does appear to extend beyond 11 months.</p>
<p>I hope this helps and thanks for writing in with that observation. Let&#8217;s see if Coleman updates his Linkedin profile.</p>
<p>Regards<br />
ed</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Larry McGee</title>
		<link>http://www.pharmalot.com/2008/02/meet-mike-your-generic-biologics-lobbyist/#comment-150756</link>
		<dc:creator>Larry McGee</dc:creator>
		<pubDate>Mon, 11 Feb 2008 13:59:58 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2008/02/meet-mike-your-generic-biologics-lobbyist/#comment-150756</guid>
		<description>Is this the same Mike Coleman?  11 months is reported as 8 years experience?  

http://www.linkedin.com/pub/5/630/797
Mike Coleman’s Experience

    *
      Scientist II
      Insmed

      (Biotechnology industry)

      April 2007 — Present (11 months)

Perhaps there is reason to be skeptical of generic claims to equivalence. Innovative companies just ask generic producers to provide the data that supports their claim. If they are confident their products are effective and safe, just show the data.</description>
		<content:encoded><![CDATA[<p>Is this the same Mike Coleman?  11 months is reported as 8 years experience?  </p>
<p><a href="http://www.linkedin.com/pub/5/630/797" rel="nofollow">http://www.linkedin.com/pub/5/630/797</a><br />
Mike Coleman’s Experience</p>
<p>    *<br />
      Scientist II<br />
      Insmed</p>
<p>      (Biotechnology industry)</p>
<p>      April 2007 — Present (11 months)</p>
<p>Perhaps there is reason to be skeptical of generic claims to equivalence. Innovative companies just ask generic producers to provide the data that supports their claim. If they are confident their products are effective and safe, just show the data.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
